SP
Sirisha Pilla
About Sirisha Pilla
Data last updated:
Sirisha Pilla is a Director at Slava Therapeutics Private Limited (since 2017) and Additional Director at Antler Life Sciences Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹16.22 Cr; the largest is Slava Therapeutics Private Limited at ₹12.14 Cr (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jul 2017 | 2017 | ₹12.14 Cr (FY 2020) | Active | |
| Additional Director | 01 Mar 2021 | 2019 | ₹4.08 Cr (FY 2020) | Active |
Board colleagues of Sirisha Pilla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohana Krishna Gopinath | 02964817 | Slava Therapeutics Private Limited , Antler Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sirisha Pilla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sirisha Pilla
Sirisha Pilla currently holds 2 directorships: Slava Therapeutics Private Limited (Director, since 06 Jul 2017, revenue ₹12.14 Cr (FY 2020)); Antler Life Sciences Private Limited (Additional Director, since 01 Mar 2021, revenue ₹4.08 Cr (FY 2020)).
Sirisha Pilla was first appointed on 06 Jul 2017 as Director at Slava Therapeutics Private Limited. The most recent appointment on record is 01 Mar 2021 at Antler Life Sciences Private Limited.
The 2 current companies of Sirisha Pilla that report revenue have a combined latest revenue of ₹16.22 Cr: Slava Therapeutics Private Limited ₹12.14 Cr (FY 2020); Antler Life Sciences Private Limited ₹4.08 Cr (FY 2020).
The current boards of Sirisha Pilla's companies include Mohana Krishna Gopinath (Slava Therapeutics Private Limited).